Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Alexza Pharmaceuticals (ALXA)

Add to Watchlists
Create an Alert
4.32 +0.08  +1.89% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
ALXA Price Chart
View All Events

ALXA Events

Date Type Description
Mar 06 Misc Q4 and Year End 2013 Alexza Pharmaceuticals, Inc. Earnings Conference Call
Mar 06 Earnings Q4 and Year End 2013 Alexza Pharmaceuticals, Inc. Earnings Results. Estimate: -0.71.
Nov 06 Misc Q3 2013 Alexza Pharmaceuticals, Inc. Earnings Conference Call
Nov 06 Earnings Alexza to Report 2013 Third Quarter Financial Results on Wednesday, November 6, 2013. Estimate: -0.41.
Aug 08 Misc Q2 2013 Alexza Pharmaceuticals, Inc. Earnings Conference Call
Aug 08 Earnings Alexza to Report 2013 Second Quarter Financial Results on Thursday, August 8, 2013. Estimate: -0.50.
May 21 Misc AGM Event for Alexza Pharmaceuticals Inc
May 09 Misc Q1 2013 Alexza Pharmaceuticals, Inc. Earnings Conference Call
May 09 Earnings Alexza to Report 2013 First Quarter Financial Results on Thursday, May 9, 2013. Estimate: -0.53.
View All Performance Charts

ALXA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alexza Pharmaceuticals is down 1.37% over the last year vs S&P 500 Total Return up 22.59%, Forest Laboratories up 153.7%, and Teva Pharmaceutical up 37.48%.

Get Quote for
Advertisement

Portfolio Strategies Featuring ALXA

Did Alexza Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ALXA Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Alexza Pharmaceuticals, Inc. is a pharmaceutical company engaged in the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. ADASUVE is its only approved product.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ALXA 4.32 +0.08 +1.89% 74.65M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.